miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Martino, Maria Teresa, Arbitrio, Mariamena, Caracciolo, Daniele, Cordua, Alessia, Cuomo, Onofrio, Grillone, Katia, Riillo, Caterina, Caridà, Giulio, Scionti, Francesca, Labanca, Caterina, Romeo, Caterina, Siciliano, Maria Anna, D'Apolito, Maria, Napoli, Cristina, Montesano, Martina, Farenza, Valentina, Uppolo, Valentina, Tafuni, Michele, Falcone, Federica, D'Aquino, Giuseppe, Calandruccio, Natale Daniele, Luciano, Francesco, Pensabene, Licia, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891816/
https://www.ncbi.nlm.nih.gov/pubmed/35282417
http://dx.doi.org/10.1016/j.omtn.2022.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891816/
https://www.ncbi.nlm.nih.gov/pubmed/35282417
http://dx.doi.org/10.1016/j.omtn.2022.02.005

Ejemplares similares